4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000076
Chief Medical Officer sold 11,366 shares at $14.59 ($165,879)
- Chief Medical Officer acquired 6,349 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-07-14 | Option exercise 10b5-1 | +6,349 | $1.08 | $6,857 | 109,273 | D |
| Rodman David Malcom Chief Medical Officer | 2025-07-14 | Sale 10b5-1 | −11,366 | $14.59 | $165,879 | 97,907 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2025-07-14 | Option exercise · Stock Option 10b5-1 | −6,349 | 88,880 | D | ||
| Open-market sales · 11,366 sh · avg $14.59 · $165,879 | |||||||
Loading xslF345X05/wk-form4_1752613231.xml…